These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28719063)

  • 1. Enhanced Fibrinolysis with Magnetically Powered Colloidal Microwheels.
    Tasci TO; Disharoon D; Schoeman RM; Rana K; Herson PS; Marr DWM; Neeves KB
    Small; 2017 Sep; 13(36):. PubMed ID: 28719063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breaking the fibrinolytic speed limit with microwheel co-delivery of tissue plasminogen activator and plasminogen.
    Disharoon D; Trewyn BG; Herson PS; Marr DWM; Neeves KB
    J Thromb Haemost; 2022 Feb; 20(2):486-497. PubMed ID: 34882946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetically powered microwheel thrombolysis of occlusive thrombi in zebrafish.
    Pontius MHH; Ku CJ; Osmond MJ; Disharoon D; Liu Y; Warnock M; Lawrence DA; Marr DWM; Neeves KB; Shavit JA
    Proc Natl Acad Sci U S A; 2024 Mar; 121(10):e2315083121. PubMed ID: 38408253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetically Powered Microwheel Thrombolysis of Occlusive Thrombi in Zebrafish.
    Pontius MHH; Ku CJ; Osmond M; Disharoon D; Liu Y; Marr DWM; Neeves KB; Shavit JA
    bioRxiv; 2023 Sep; ():. PubMed ID: 37745422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microfluidic Modeling of Thrombolysis.
    Loyau S; Ho-Tin-Noé B; Bourrienne MC; Boulaftali Y; Jandrot-Perrus M
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2626-2637. PubMed ID: 30354249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time measurement of lysis of mural platelet deposits by fibrinolytic agents under arterial flow.
    Graham DA; Huang TC; Keyt BA; Alevriadou BR
    Ann Biomed Eng; 1998; 26(4):712-24. PubMed ID: 9662163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
    Singh S; Houng A; Reed GL
    Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface-enabled propulsion and control of colloidal microwheels.
    Tasci TO; Herson PS; Neeves KB; Marr DW
    Nat Commun; 2016 Jan; 7():10225. PubMed ID: 26725747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
    Wu JH; Diamond SL
    J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel and emerging therapies: thrombus-targeted fibrinolysis.
    Lippi G; Mattiuzzi C; Favaloro EJ
    Semin Thromb Hemost; 2013 Feb; 39(1):48-58. PubMed ID: 23034825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface.
    Braaten JV; Jerome WG; Hantgan RR
    Blood; 1994 Feb; 83(4):982-93. PubMed ID: 8111066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An experimental and theoretical study on the dissolution of mural fibrin clots by tissue-type plasminogen activator.
    Wootton DM; Popel AS; Alevriadou BR
    Biotechnol Bioeng; 2002 Feb; 77(4):405-19. PubMed ID: 11787013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A faster-acting and more potent form of tissue plasminogen activator.
    Keyt BA; Paoni NF; Refino CJ; Berleau L; Nguyen H; Chow A; Lai J; Peña L; Pater C; Ogez J
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3670-4. PubMed ID: 8170967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of c7E3 Fab on thrombus formation and rt-PA-Mediated thrombolysis under flow conditions.
    Huang TC; Jordan RE; Hantgan RR; Alevriadou BR
    Thromb Res; 2001 Jun; 102(5):411-25. PubMed ID: 11395127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic fibrinolysis: The combined effects of tissue plasminogen activator and recombinant staphylokinase in vitro.
    Aisina R; Mukhametova L; Varfolomeyev S
    Biochim Biophys Acta; 2016 Apr; 1860(4):629-35. PubMed ID: 26723174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological control of tissue plasminogen activator-mediated fibrinolysis.
    Rånby M; Brändström A
    Enzyme; 1988; 40(2-3):130-43. PubMed ID: 3139402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.
    Sakharov DV; Barrertt-Bergshoeff M; Hekkenberg RT; Rijken DC
    Thromb Haemost; 1999 Apr; 81(4):605-12. PubMed ID: 10235448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus.
    Braaten JV; Handt S; Jerome WG; Kirkpatrick J; Lewis JC; Hantgan RR
    Blood; 1993 Mar; 81(5):1290-9. PubMed ID: 8443390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potentiating effect of platelet on plasminogen activation by tissue plasminogen activator.
    Deguchi K; Murashima S; Shirakawa S; Soria C; Soria J; Dunn F; Tobelem G
    Thromb Res; 1985 Dec; 40(6):853-61. PubMed ID: 3937289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.